Zobrazeno 1 - 10
of 399
pro vyhledávání: '"Mkrtumyan A."'
Autor:
N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. А. Lukina, A. M. Mkrtumyan, N. А. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 402-404 (2024)
An erratum on « Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice» by Natalya G. Mokrysheva, Marina V. Shestakova, Alexander S. Ametov, Mikhail B. Antsiferov, Igor G. Bakulin, Tatiana V. Vavilova, Gagik R. Galstya
Externí odkaz:
https://doaj.org/article/f3a3e60a6bf642f988972646d18271a9
Autor:
M. B. Antsiferov, O. N. Kotenko, Z. D. Kobalava, T. Y. Demidova, T. N. Markova, V. V. Tolkacheva, L. Y. Morgunov, A. V. Andreeva, E. Y. Pashkova, M. R. Khaziakhmetova, E. S. Samburova, S. G. Vedyashkina, A. M. Mkrtumyan, N. А. Petunina, А. N. Serebrov, T. M. Deeva, A. Y. Karaeva
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 204-213 (2024)
AIM: To assess the prevalence of chronic kidney disease (CKD), clinical and demographic characteristics and therapy profile in patients with type 2 diabetes admitted to multidisciplinary hospitals. CREDO (Cardio-REnal Diabetic cOmplications) trial wa
Externí odkaz:
https://doaj.org/article/9acc7186593c4c55aed7d369c8c2532e
Autor:
N. G. Mokrysheva, M. V. Shestakova, A. S. Ametov, M. B. Antsiferov, I. G. Bakulin, T. V. Vavilova, G. R. Galstyan, T. Y. Demidova, F. K. Dzgoeva, T. L. Karonova, E. A. Lukina, A. M. Mkrtumyan, N. A. Petunina, R. V. Ponomaryov, N. A. Suponeva, O. Y. Sukhareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 314-320 (2024)
On March 20, 2024, an interdisciplinary meeting of the Expert Council on the current problem of B12 insufficiency/deficiency and the prevalence of this condition among endocrine patients was held at the Endocrinology Research Centre (Moscow). The pur
Externí odkaz:
https://doaj.org/article/8829d05cc33f43caab1c815842313903
Autor:
Ashot M. Mkrtumyan
Publikováno v:
Терапевтический архив, Vol 96, Iss 4, Pp 419-428 (2024)
In the contemporary reality pharmacological correction of the early carbohydrate metabolism disorders is the main method for the type 2 diabetes prevention. Taking into account the main role of insulin resistance in the prediabetes development it can
Externí odkaz:
https://doaj.org/article/31675a1739eb4f31b3271eab13538c6c
Autor:
M. B. Antsiferov, Zh. D. Kobalava, T. Y. Demidova, T. N. Markova, V. V. Tolkacheva, L. Y. Morgunov, A. V. Andreeva, Е. Y. Pashkova, M. R. Khaziakhmetova, E. S. Samburova, S. G. Vedyashkina, A. M. Mkrtumyan, N. А. Petunina, A. N. Serebrov, T. M. Deeva, A. Y. Karaeva
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 4-14 (2024)
BACKROUND: Heart failure (HF) is in the first place in the structure of cardiovascular death in patients with type 2 diabetes mellitus (T2D). One of the factors determining the prognosis of patients with this pathology is hospitalization. The difficu
Externí odkaz:
https://doaj.org/article/d5cde38ed9fb487b9cd59a4a1e637bcf
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 585-595 (2023)
Metformin, known in the medical community as the drug of first choice for type 2 diabetes mellitus, belongs to the group of biguanides and has proven to be an effective treatment in clinical practice. Our knowledge of the pharmacodynamic properties o
Externí odkaz:
https://doaj.org/article/22e635b6c2d9481bb298ea809e279f27
Autor:
M. V. Shestakova, G. R. Vagapova, O. K. Vikulova, G. R. Galstyan, T. Yu. Demidova, E. N. Dudinskaya, T. P. Kiseleva, A. M. Mkrtumyan, N. A. Petunina, O. N. Tkacheva, V. V. Fadeev, Y. S. Khalimov, E. A. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 619-625 (2023)
TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for regular review of proven therapeutic solutions. Today, dipeptidyl peptidase-4 inhibitors (DP
Externí odkaz:
https://doaj.org/article/a9f62b279e3c4b2aa4fd5e55d9c3b6e3
Autor:
M. V. Shestakova, V. A. Dobronravov, A. S. Ametov, M. B. Antsiferov, M. M. Batyushin, I. N. Bobkova, G. R. Galstyan, T. Y. Demidova, V. V. Klimontov, A. M. Mkrtumyan, N. A. Petunina, E. I. Prokopenko, N. V. Chebotareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 492-499 (2023)
Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is one of the most important medical and social problems associated with significant risks for patients and a burden on the national healthcare system. There are significant unmet di
Externí odkaz:
https://doaj.org/article/cd40d33465dc4112b3b1b1597d367b81
Autor:
M. V. Shestakova, G. R. Galstyan, E. N. Grineva, A. V. Zilov, T. Yu. Demidova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, O. Y. Sukhareva, L. A. Suplotova, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 484-491 (2023)
Over the past 10 years of studying the complications of type 2 diabetes mellitus (DM) and ways to deal with them, significant progress has been made in one of the most important areas of treatment — the prevention of cardiovascular and renal compli
Externí odkaz:
https://doaj.org/article/cc8bbcd485854342af83849fedacb388
Autor:
M. B. Antsiferov, G. R. Galstyan, T. Yu. Demidova, A. V. Zilov, T. N. Markova, А. M. Mkrtumyan, N. A. Petunina, I. S. Khalimov, M. S. Shamkhalova, M. V. Shestakova
Publikováno v:
Сахарный диабет, Vol 26, Iss 2, Pp 211-214 (2023)
Type 2 diabetes is characterized by increasing incidence and prevalence all-over the world. Current therapeutic management of type 2 diabetes is complex and is based not only on glycemic control, but also on cardiovascular and renal risks reduction.
Externí odkaz:
https://doaj.org/article/d859b678f86d4281a70004385fe60c28